@article{10.37349/ebmx.2024.00004
abstract = {Translating biomaterials research into clinical products is a multidisciplinary yet rewarding journey. It should primarily aim to improve patient treatment and clinical outcomes by addressing unmet clinical needs. Four examples of commercial development of biomaterial implants illustrate the diversity of paths, starting from academic research work (AlchiMedics, TISSIUM, Cousin Surgery) or corporate initiatives to develop new products (Medtronic-Sofradim Production). They have been selected from the Translational Research session of the 2022 Conference of the European Society for Biomaterials (ESB) in Bordeaux (France). Commitment, agility, and perseverance were among the key common skills to successfully meet challenges, especially the most unexpected ones. All dimensions of translation projects must be integrated from the start, including the regulatory strategy.},
author = {Bayon, Yves and Bureau, Christophe and Perreira, Maria J N and Aubert, François and Caillibotte, Michel and Vestberg Robert and Letourneur, Didier},
doi = {https://doi.org/10.37349/ebmx.2024.00004},
journal = {Exploration of BioMat-X},
pages = {23--33},
title = {{Journey of medical device development from the bench to the bedside—four real-life examples of commercial biomaterials development}},
url = {https://www.explorationpub.com/Journals/ebmx/Article/10134},
volume = {1},
year = {2024},
number = {1}
}